Pan-cancer analysis showed that ALYREF overexpression was significantly associated with advanced tumor-lymph node metastasis stage and poor HCC prognosis (Xue et al., 2021), so the constructed immune prognostic model could effectively evaluate patients. The gene discussed is ALYREF; the disease is hepatocellular carcinoma.